ACE2 and breast carcinoma: Overall, we found that lower expression level of ACE2 was related to poorer prognosis of breast cancer in enriched CD8+ T cells (p=0.04), enriched CD4+ T cells (p=0.04) and enriched dendritic cells (p=0.04).